Replication and Fine Mapping for Association of the C2orf43, FOXP4, GPRC6A and RFX6 Genes with Prostate Cancer in the Chinese Population by Long, Qing-Zhi et al.
Replication and Fine Mapping for Association of the
C2orf43, FOXP4, GPRC6A and RFX6 Genes with Prostate
Cancer in the Chinese Population
Qing-Zhi Long
1*
., Yue-Feng Du
1., Xiao-Ying Ding
2, Xiang Li
1, Wen-Bin Song
1, Yong Yang
3, Peng Zhang
4,
Jian-Ping Zhou
5, Xiao-Gang Liu
6
1Department of Urology, the First Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an Shaanxi, People’s Republic of China, 2Department of Anesthesia,
the Second Affiliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an Shaanxi, People’s Republic of China, 3Department of Urology, The Affiliated Xi’an Ninth
Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an Shaanxi, People’s Republic of China, 4Department of Urology, The Second Affiliated Hospital, School of
Medicine, Xi’an Jiaotong University, Xi’an Shaanxi, People’s Republic of China, 5Department of Urology, The Third Affiliated Hospital, School of Medicine, Xi’an Jiaotong
University, Xi’an Shaanxi, People’s Republic of China, 6The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and
Technology, Xi’an Jiaotong University, Xi’an Shaanxi, People’s Republic of China
Abstract
Background: Prostate cancer represents the leading cause of male death across the world. A recent genome-wide
association study (GWAS) identified five novel susceptibility loci for prostate cancer in the Japanese population. This study is
to replicate and fine map the potential association of these five loci with prostate cancer in the Chinese Han population.
Methods: In Phase I of the study, we tested the five single nucleotide polymorphisms (SNPs) which showed the strongest
association evidence in the original GWAS in Japanese. The study sample consists of 1,169 Chinese Hans, comprising 483
patients and 686 healthy controls. Then in phase II, flanking SNPs of the successfully replicated SNPs in Phase I were
genotyped and tested for association with prostate cancer to fine map those significant association signals.
Results: We successfully replicated the association of rs13385191 (located in the C2orf43 gene, P=8.60610
25), rs12653946
(P=1.33610
26), rs1983891 (FOXP4, P=6.22610
25), and rs339331 (GPRC6A/RFX6, P=1.42610
25) with prostate cancer. The
most significant odds ratio (OR) was recorded as 1.41 (95% confidence interval 1.18–1.68) for rs12653946. Rs9600079 did not
show significant association (P=8.07610
22) with prostate cancer in this study. The Phase II study refined these association
signals, and identified several SNPs showing more significant association with prostate cancer than the very SNPs tested in
Phase I.
Conclusions: Our results provide further support for association of the C2orf43, FOXP4, GPRC6A and RFX6 genes with
prostate cancer in Eastern Asian populations. This study also characterized the novel loci reported in the original GWAS with
more details. Further work is still required to determine the functional variations and finally clarify the underlying biological
mechanisms.
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Introduction
Prostate cancer (MIM 176807) represents the leading cause of
male death in Western countries. With lifestyle transition, it has
also become more and more prevalent in Asia. It is widely
accepted that genetics play important roles in susceptibility to
almost all human cancers. Now, genome-wide association study
(GWAS) has become a feasible, powerful and effective approach
for identification of novel genes underlying susceptibility to cancers
and other complex diseases.
A recently conducted GWAS on prostate cancer identified
five novel susceptibility loci in the Japanese population [1].
These loci had not been associated with prostate cancer before.
Investigation in diverse populations of the variants discovered
from GWASs may contribute to a more comprehensive
understanding of genetic mechanisms of prostate cancer. Here,
we report our replication efforts in the Chinese Han population
for potential association of these five loci with prostate cancer.
Specifically, five SNPs that showed the strongest association
evidence respectively in their situated loci in the original GWAS
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prostate cancer. This is the first replication study on these five
novel loci with prostate cancer in the Chinese population.
Furthermore, as an effort to fine map the replicated association
signals, we genotyped a total of another 259 SNPs encompass-
ing the successfully replicated SNPs and tested for their
association with prostate cancer.
Materials and Methods
Ethics Statement
The study was approved by the institutional review board of
Xi’an Jiaotong University. Signed informed-consent documents
were obtained from all study participants.
Study Sample
The study sample consisted of 483 patients and 686 healthy
geography- and age-matched controls. The patients were recruited
from in- and outpatients of the participating hospitals from 2007 to
the present. All patients were independently and consistently
diagnosed by two senior urologists and a senior pathologist based
on medical records and pathological evaluation of prostate biopsy.
We preferentially recruited patients who had a self-reported family
history of prostate cancer or a high-grade Gleason score ($7) at
the time of diagnosis. Each study subject filled in a structured
questionnaire form covering family history, medical history,
alcohol consumption, smoking, diet structure, socioeconomic
factors, etc. The control subjects were drawn from a growing
database comprising more than 3,000 randomly-enrolled unrelat-
ed Han Chinese from Xi’an city and its neighboring area.
Individuals having serious chronic diseases/conditions that may
have potential influence on endocrine and metabolism were
excluded. The inclusion and exclusion criteria have been
described in details elsewhere [2,3]. Potential confounding factors,
including native place, alcohol consumption, smoking, diet
structure and socioeconomic factors, were maximally considered
to match the patient and control groups.
SNP Selection and Genotyping
In Phase I, we selected the five SNPs that showed the strongest
association evidence respectively in their situated loci in the
original GWAS. As for Phase II, the SNP markers were selected
based on a comprehensive consideration of: (1) coverage of the
coding sequence and up to 300 kbp upstream of the gene under
scrutiny; (2) validation of the SNP from both dbSNP and HapMap
databases; (3) degree of heterozygosity, i.e., minor allele frequency
$5%; (4) inclusion of the SNP in Affymetrix and Illumina SNP
chips. This is for convenience of comparison of association results
between this study and others.
Genomic DNA was extracted from peripheral blood leuko-
cytes applying standard protocols. SNP genotyping was
performed with a primer-extension method with MALDI-TOF
mass spectrometry on a MassARRAY system as suggested by
the manufacturer (Sequenom, Inc., San Diego, CA). Genotype
frequencies of all the five SNPs in both case and control groups
did not deviate significantly from Hardy-Weinberg equilibrium
(P.0.05). In phase II, 66, 40 and 81 SNPs were successfully
genotyped and past the Hardy-Weinberg equilibrium test,
respectively for the loci around the C2orf43 (Chromosome 2
Open Reading Frame [MIM 613570]), FOXP4 (Forkhead Box
P4 [MIM 608924]) and GPRC6A/RFX6 (G Protein-coupled
Receptor, family C, group 6, member A [MIM 613572] and
regulatory factor X, 6 [MIM 612659]) genes. Given rs12653946
was not mapped to any known gene, 72 flanking SNPs of
rs12653946 were genotyped in phase II.
Statistical Analyses
The genotype distributions of the tested SNPs between case and
control groups were analyzed with logistic regression models
controlling for age and alcohol consumption as covariates. In the
frame of logistic regression model, odds ratio (OR) with the
corresponding 95% confidence intervals were also computed. We
adopted the conservative Bonferroni method to account for the
multiple-testing problem respectively for the study of Phase I and
Phase II. Because five SNPs were tested in the replication phase,
the significance level was set as 1.00610
22 (i.e., 0.05/5). In phase
II, the significance level for the study was set as 1.93610
24 (i.e.,
0.05/259).
We utilized online FASTSNP (http://fastsnp.ibms.sinica.edu.
tw) in order to analyze the potential functions of the pinpointed
SNPs. The analysis is based on up-to-date information extracted
from 11 external bioinformatic databases at query time [4].
Results
Clinical characteristics of the patient subjects are presented in
Table 1. The average age of patients and controls was 67.366.9
and 66.366.4, respectively. All study subjects are Han Chinese
recruited from the Xi’an city and its neighboring area. Our
previous studies [2,3] did not detect significant population
stratification in the study sample database, from which all the
control subjects of this study were drawn. Some interesting
characteristics of the case and control samples are presented in
Table 2.
Our results of the Phase I study provided supportive evidence
for four of the five tested SNPs as true susceptibility loci of prostate
cancer. We confirmed association of rs13385191, rs12653946,
Table 1. Clinical characteristics of the patient subjects.
Number (%)
Tumor stage
T0 4 (0.8)
T1 47 (9.7)
T2 70 (14.5)
T3 41 (8.5)
T4 9 (1.9)
Missing data 310 (64.2)
Nodal stage
N0 144 (29.8)
N1 11 (2.3)
Missing data 327 (67.7)
Metastasis stage
M0 179 (37.1)
M1 13 (2.7)
Missing data 290 (60.0)
Gleason score
GS ,7 120 (24.8)
GS $7 143 (29.6)
Missing data 219 (45.3)
doi:10.1371/journal.pone.0037866.t001
Association of Four Genes with Prostate Cancer
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25, 1.33610
26,
6.22610
25, and 1.42610
25, respectively, with the same high-risk
alleles to those in the original GWAS in the Japanese population.
Characteristics of the studied SNPs and corresponding association
test results in the replication phase are showed in Table 3.
In Phase II, we found two SNPs showing even stronger
association than their corresponding two SNPs tested in Phase I.
Rs16988102 obtained a P value of 5.29610
25 compared to
rs13385191 with a P value of 8.60610
25. Rs9489065 got a P
value of 1.40610
25, compared to rs339331 with a P value of
1.42610
25. When jointly modeling prostate cancer with
rs16988102 and rs13385191, the OR (95% CI) increased to
1.71 (1.47–1.96), compared to OR of 1.33 (1.11–1.58) when
considering rs13385191 alone. When jointly modeling the four
SNPs which got the most significant association signals in their
respective loci, the OR (95% CI) turned out 2.06 (1.79–2.35).
LD (linkage disequilibrium) structure of the tested SNPs and
results of the association tests in Phase II for the four loci
around rs13385191, rs12653946, rs1983891, and rs339331 are
presented in Figure 1, 2, 3 and 4. The LD map was generated
by the use of Haploview (Broad Institute, MA, USA) based on
D-Prime using the genotype data of case and controls in the
Phase II study.
Discussion
Rs13385191 is located in intron region of the C2orf43 gene,
which encoding a hypothetical protein LOC60526. The C2orf43
gene is conserved among chimpanzee, cow, mouse, rat, chicken,
zebrafish, fruit fly, mosquito, C.elegans, A.thaliana, and rice. This
suggests the existence of important functional variants around the
gene region. Notably, the chromosome region 2p24 harboring the
C2orf43 gene was linked to prostate cancer in European and
American populations [5]. This complies with the detected
association of the C2orf43 gene with prostate cancer in this study.
FASTSNP analyses suggested that rs13385191 may be a location
of intronic enhancer.
Rs1983891 is mapped to intron region of the FOXP4 gene. The
FOXP4 gene was first reported as a novel forkhead transcription
factor [6]. FOXP4 belongs to subfamily P of the forkhead box
(FOX) transcription factor family. Forkhead box transcription
factors play important roles in the regulation of tissue- and cell
type-specific gene transcription. Many members of the forkhead
box gene family, including members of subfamily P, participate in
mammalian oncogenesis [6]. The FOXP4 gene is located at
chromosome region 6p21, which region was also ever linked to
prostate cancer [5,7].
Rs339331 resides close to two genes, GPRC6A and RFX6.
FASTSNP showed that rs339331 may be a location of intronic
enhancer of the GPRC6A gene. Prostate does not express
GPRC6A in normal conditions [8]. Nevertheless, interestingly,
GPRC6A is highly expressed in the Leydig cells of the testis, and
mice deficient in Gprc6a show male feminization and a metabolic
manifestation of higher circulating estradiol and reduced levels of
testosterone. These two hormones are critical for initiation and
progression of prostate cancer [9]. As another supporting evidence
for the significant association, GPRC6A is functionally important
in regulating non-genomic effects of androgens in multiple tissues
[10]. Rs339331 resides in the chromosome region 6q22, which was
found to be a susceptibility loci of prostate cancer in US Whites
[11].
The RFX6 gene encodes a member of the regulatory factor X
(RFX) family of transcription factors [12]. The coded DNA-
binding protein RFX6 plays an important role in the pathology of
neonatal hemochromatosis [13]. Association of the HFE (hemo-
chromatosis) gene with prostate cancer [14] highlight the crosstalk
between pathology of hemochromatosis and prostate cancer.
Table 2. Characteristics of the case and control samples.
Case
n=483
Control
n=686
Average Age (years, 6 SD) 67.3 (66.9) 66.3 (66.4)
Average Height (m, 6 SD) 161.4 (68.6) 162.1 (68.8)
Average Weight (kg, 6 SD) 62.6 (610.6) 63.2 (610.2)
Percentage of regular smokers
a 46.8% 45.1%
Percentage of regular alcohol
consumers
b
31.2% 28.9%
Annual household income (RMB) 31,200 33,600
Note: Abbreviations: SD, standard deviation;
RMB, RenMinBi, the legal tender of mainland China;
aRegular smokers refer to subjects who smoke at least half a pack of cigarettes
per day;
bRegular alcohol consumers refer to subjects who drink at least two times per
week.
doi:10.1371/journal.pone.0037866.t002
Table 3. Association test results and characteristics of the studied SNPs in the replication phase.
dbSNP ID Association test results OR
a Region
b Location
a Role Gene
b Alleles
c Minor allele and MAF
Original GWAS Our data HapMap Our data
CHB JPT CEU
rs13385191 7.5610
28 8.60610
25 1.33 (1.11–1.58) 2p24 20751746 Intron C2orf43 G/A G(0.49) A(0.37) G(0.20) A(0.44)
rs12653946 3.9610
218 1.33610
26 1.41 (1.18–1.68) 5p15 1948829 / T/C T(0.35) T(0.43) T(0.43) T(0.39)
rs1983891 7.6610
28 6.22610
25 1.34 (1.13–1.59) 6p21 41644405 Intron FOXP4 T/C T(0.37) T(0.38) T(0.27) T(0.38)
rs339331 1.6610
212 1.42610
25 1.39 (1.16–1.65) 6q22 117316745 Intron GPRC6A/RFX6 T/C C(0.35) C(0.40) C(0.36) C(0.37)
rs9600079 2.8610
29 8.07610
22 1.07 (0.88–1.27) 13q22 72626140 / T/G T(0.48) T(0.32) T(0.46) T(0.39)
Note: MAF, minor allele frequency. UTR, untranslated region;
aOdds ratio followed by 95% confidence interval;
bRegion and location are based on HapMap data release#24;
bBlank cells mean the SNPs are not mapped to any gene;
cThe risk allele is placed prior to the slash.
doi:10.1371/journal.pone.0037866.t003
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Nevertheless, 5p15, the locus harboring the rs12653946 polymor-
phism, was ever linked to prostate cancer aggressiveness [15,16].
This is in accordance with the detected association of rs12653946
with prostate cancer in this study.
Possible reasons for failure of replication for rs9600079 might
include different ethnic backgrounds, difference in selection
criteria of study subjects, and/or ethnic heterogeneity of genetics
mechanisms of prostate cancer.
In Phase II of fine mapping for the replicated loci in Phase I,
rs16988102 and rs9489065 got more significant association signals
with prostate cancer than their neighboring SNPs replicated in
Phase I. The association of Rs16988102 with prostate cancer was
also supported by strong associations of multiple surrounding
SNPs with prostate cancer. Rs16988102 is located in 59 upstream
of the C2orf43 gene. The distance between rs16988102 and
rs13385191 is more than 300 kb, which is much longer than
general distance of LD. Thus, we prefer to claim the rs16988102 as
a risk locus for prostate cancer independent to rs13385191. This is
in accordance with the significantly lifted OR by adding
rs16988102 to the risk model of prostate cancer which only took
the variation of rs13385191 into account. Rs9489065 is located in
Figure 1. LD maps of the tested SNPs and association test results for the loci around rs13385191 in Phase II.
doi:10.1371/journal.pone.0037866.g001
Figure 2. LD maps of the tested SNPs and association test results for the loci around rs12653946 in Phase II.
doi:10.1371/journal.pone.0037866.g002
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strong LD (D9=0.97), and their association signals with prostate
cancer are largely comparative. This implies that one of rs9489065
and rs339331 is the true susceptibility loci, or that both these two
SNPs are in strong LD with the true susceptibility loci. Notably,
around the loci of the GPRC6A and RFX6 genes, the SNPs
significantly associated with prostate cancer narrowed to the
region of the RFX6 gene, compared to a wide distribution of
significantly associated SNPs across the whole region of these two
genes in the original GWAS. This suggests the RFX6 gene
variation may be the susceptibility loci underlying the observed
association signal of the GPRC6A/RFX6 loci with prostate cancer
in the original GWAS.
In the original GWAS, Takata et al. failed to replicate
association of 12 SNPs among the total of tested 31 SNPs which
are significantly associated with prostate cancer in European
populations. This highlighted the genetic heterogeneity of prostate
cancer among diverse ethnic populations. In this study, four
Figure 3. LD maps of the tested SNPs and association test results for the loci around rs1983891 in Phase II.
doi:10.1371/journal.pone.0037866.g003
Figure 4. LD maps of the tested SNPs and association test results for the loci around rs339331 in Phase II.
doi:10.1371/journal.pone.0037866.g004
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prostate cancer in Japanese are successfully replicated in Chinese
Han population. Compared with the replication ratio of 12/31,
the sharply higher replication ratio of 4/5 raised the possibility of
similar genetic pathology of prostate cancer between the Japanese
and Chinese Han populations. This is not unexpected given the
genetic homogeneity between the Chinese and Japanese popula-
tions [17].
In summary, our results provide further evidence for significant
association of SNPs rs13385191, rs12653946, rs1983891, and
rs339331 with susceptibility to prostate cancer in Eastern Asian
populations. The related genes, C2orf43, FOXP4, GPRC6A and
RFX6, are warranted for further efforts to determine the functional
variations and finally to clarify the genetic mechanism of
susceptibility to prostate cancer.
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